Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Queensland Health
Boehringer Ingelheim
McKinsey
Argus Health
Cipla
Dow
Cantor Fitzgerald

Generated: June 20, 2018

DrugPatentWatch Database Preview

DELSYM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Delsym, and when can generic versions of Delsym launch?

Delsym is a drug marketed by Reckitt Benckiser and is included in one NDA.

The generic ingredient in DELSYM is dextromethorphan polistirex. There are twenty-three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the dextromethorphan polistirex profile page.
Drug patent expirations by year for DELSYM
Medical Subject Heading (MeSH) Categories for DELSYM
Synonyms for DELSYM
( )-3-Methoxy-N-methylmorphinon
( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren
(+)-3-methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
(+)-3-Methoxy-17-methylmorphinan
(+)-Dextromethorphan
(1R,9R,10R)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.0;{1,10}.0;{2,7}]heptadeca-2,4,6-triene
(1S,9S,10S)-4-METHOXY-17-METHYL-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2,4,6-TRIENE
(4bR,8aS,9R)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene
(9a,13a,14a)-3-Methoxy-17-methylmorphinan
(9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan
125-69-9 (hydrobromide)
125-71-3
18046-32-7
18609-21-7 (hydrochloride)
3-Methoxy-17-methyl-9.alpha.,13.alpha.-morphinan
3-Methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan
3-Methoxy-17-methyl-9a,13a,14a-morphinan
3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
3-Methoxy-17-methylmorphinan-, (9.alpha.,13.alpha.,14.alpha.)- #
3-Methoxy-N-methylmorphinon
32062-10-5
4-21-00-01367 (Beilstein Handbook Reference)
6700-34-1 (hydrobromide, mono-hydrate)
7355X3ROTS
9-alpha,13-alpha,14-alpha-Morphinan, 3-methoxy-17-methyl-
9.alpha.,13.alpha.,14.alpha.-Morphinan, 3-methoxy-17-methyl-
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl-
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI)
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl-(8CI)
AJ-44755
AKOS025311415
Albutussin
API0009162
BA 2666
Balminil DM
Balminil DM Children
BDBM50366613
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
BPBio1_000503
BRD-K33211335-337-03-7
BRN 0088549
BSPBio_000457
C-17088
C06947
Calmylin #1
Canfodion
CC-26377
CHEBI:92579
CHEMBL52440
Cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren
Cosylan
Cough-X
Creo-Terpin
CTK8F9098
d-Methorphan
D03742
D09OBB
DB00514
Delsym (Salt/Mix)
Delsym Cough Formula
delta-Methorphan
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [DCIT]
Dextromethorfan
Dextromethorfan [Czech]
dextromethorphan
Dextromethorphan (USP)
Dextromethorphan [USP:INN:BAN]
Dextromethorphan Bromhydrate
Dextromethorphan HBr
Dextromethorphan hydriodide
Dextromethorphan hydrobromide
Dextromethorphan polistirex
Dextromethorphan solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Dextromethorphane
Dextromethorphane [INN-French]
Dextromethorphanum
Dextromethorphanum [INN-Latin]
Dextrometorfano
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dexyromethorphan
Diabe-Tuss DM Syrup
Dormetan
DR000870
DTXSID3022908
DXM [Antitussive]
EINECS 204-752-2
GTPL6953
Hihustan M.
HMS2090C08
Hold DM
HSDB 3056
J-005274
Koffex DM
Levomethorphan
Levomethorphan [BAN:DCF:INN]
Levomethorphan [INN:BAN:DCF]
Levomethorphane
Levomethorphanum
Levometorfano
Lopac-D-2531
LS-91838
LSM-2726
Medicon (Salt/Mix)
MKXZASYAUGDDCJ-NJAFHUGGSA-N
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)-
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI)
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)-(9CI)
Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-
Morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-
NCGC00015333-01
NCGC00015333-02
Neurodex (TN)
Nodex
Novahistex DM
Novahistine DM
Pertussin CS Children's Strength
Pertussin DM Extra Strength
PL043720
Prestwick0_000359
Prestwick1_000359
Prestwick2_000359
Prestwick3_000359
RACEMETHORPHAN
Racemethorphan [as d-form]
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin Pediatric Cough Suppressant
Romilar
Romilar (Salt/Mix)
Romilar (TN)
SC-79796
SCHEMBL29949
SPBio_002378
ST24046433
Sucrets 4 Hour Cough Suppressant
Triaminic DM Long Lasting for Children
Trocal
Tusilan (Salt/Mix)
UNII-7355X3ROTS
UNII-8YB8F78WM1 component MKXZASYAUGDDCJ-NJAFHUGGSA-N
Vicks 44 Cough Relief
ZINC3201907

US Patents and Regulatory Information for DELSYM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Reckitt Benckiser DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for DELSYM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Reckitt Benckiser DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Reckitt Benckiser DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DELSYM
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Suspension 30 mg/5 mL ➤ Subscribe 2009-01-12

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Queensland Health
Fish and Richardson
AstraZeneca
Fuji
Baxter
Federal Trade Commission
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.